144 related articles for article (PubMed ID: 38036157)
1. Somatostatin receptor2 (SSTR2) expression, prognostic implications, modifications and potential therapeutic strategies associates with head and neck squamous cell carcinomas.
Fan S; Zheng H; Zhan Y; Luo J; Zang H; Wang H; Wang W; Xu Y
Crit Rev Oncol Hematol; 2024 Jan; 193():104223. PubMed ID: 38036157
[TBL] [Abstract][Full Text] [Related]
2. SSTR2 promoter hypermethylation is associated with the risk and progression of laryngeal squamous cell carcinoma in males.
Shen Z; Chen X; Li Q; Zhou C; Li J; Ye H; Duan S
Diagn Pathol; 2016 Jan; 11():10. PubMed ID: 26796520
[TBL] [Abstract][Full Text] [Related]
3. Aberrant methylation inactivates somatostatin and somatostatin receptor type 1 in head and neck squamous cell carcinoma.
Misawa K; Misawa Y; Kondo H; Mochizuki D; Imai A; Fukushima H; Uehara T; Kanazawa T; Mineta H
PLoS One; 2015; 10(3):e0118588. PubMed ID: 25734919
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma.
Sassenberg M; Droop J; Schulz WA; Dietrich D; Loick SM; Wiek C; Scheckenbach K; Gaisa NT; Hoffmann MJ
BMC Cancer; 2019 Aug; 19(1):806. PubMed ID: 31412811
[TBL] [Abstract][Full Text] [Related]
5. Insights into metastatic roadmap of head and neck cancer squamous cell carcinoma based on clinical, histopathological and molecular profiles.
Mastronikolis NS; Delides A; Kyrodimos E; Piperigkou Z; Spyropoulou D; Giotakis E; Tsiambas E; Karamanos NK
Mol Biol Rep; 2024 Apr; 51(1):597. PubMed ID: 38683372
[TBL] [Abstract][Full Text] [Related]
6. DNA Methylation as a Diagnostic, Prognostic, and Predictive Biomarker in Head and Neck Cancer.
Liouta G; Adamaki M; Tsintarakis A; Zoumpourlis P; Liouta A; Agelaki S; Zoumpourlis V
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769317
[TBL] [Abstract][Full Text] [Related]
7. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.
Yang L; Lu P; Yang X; Li K; Chen X; Qu S
Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376
[TBL] [Abstract][Full Text] [Related]
8. Prognostic microRNA signatures derived from The Cancer Genome Atlas for head and neck squamous cell carcinomas.
Wong N; Khwaja SS; Baker CM; Gay HA; Thorstad WL; Daly MD; Lewis JS; Wang X
Cancer Med; 2016 Jul; 5(7):1619-28. PubMed ID: 27109697
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic and predictive methylation biomarkers in HNSCC : Epigenomic diagnostics for head and neck squamous cell carcinoma (HNSCC)].
Franzen A; Bootz F; Dietrich D
HNO; 2020 Dec; 68(12):911-915. PubMed ID: 32613323
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNAs in head and neck squamous cell carcinoma: biological functions and mechanisms.
Zhao J; Liu D; Yang H; Yu S; He H
Mol Biol Rep; 2020 Oct; 47(10):8075-8090. PubMed ID: 32914266
[TBL] [Abstract][Full Text] [Related]
11. Salivary epigenetic biomarkers in head and neck squamous cell carcinomas.
Lim Y; Sun CX; Tran P; Punyadeera C
Biomark Med; 2016; 10(3):301-13. PubMed ID: 26888346
[TBL] [Abstract][Full Text] [Related]
12. Transient Receptor Potential (TRP) Channels in Head-and-Neck Squamous Cell Carcinomas: Diagnostic, Prognostic, and Therapeutic Potentials.
Kiss F; Pohóczky K; Szállási A; Helyes Z
Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32887395
[TBL] [Abstract][Full Text] [Related]
13. Somatostatin receptor 2 is highly sensitive and specific for Epstein-Barr virus-associated nasopharyngeal carcinoma.
Viswanathan K; Sadow PM
Hum Pathol; 2021 Nov; 117():88-100. PubMed ID: 34416258
[TBL] [Abstract][Full Text] [Related]
14. Identification and validation of a prognostic signature of autophagy, apoptosis and pyroptosis-related genes for head and neck squamous cell carcinoma: to imply therapeutic choices of HPV negative patients.
Nan Z; Dou Y; Chen A; Wang K; Sun J; Meng Z; Neckenig M; Ai D; Liu S; Dong Z; Ma C; Cheng Y; Qu X
Front Immunol; 2022; 13():1100417. PubMed ID: 36703967
[TBL] [Abstract][Full Text] [Related]
15. MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol.
Arantes LM; Laus AC; Melendez ME; de Carvalho AC; Sorroche BP; De Marchi PR; Evangelista AF; Scapulatempo-Neto C; de Souza Viana L; Carvalho AL
Oncotarget; 2017 Feb; 8(6):9911-9921. PubMed ID: 28039483
[TBL] [Abstract][Full Text] [Related]
16. Integrated analysis of DNA methylation and mRNA expression profiles to identify key genes in head and neck squamous cell carcinoma.
Jin Y; Qin X
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31894857
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of the methylation of Wnt pathway antagonists-CXXC4, DACT2, and the inhibitors of sonic hedgehog signaling-ZIC1, ZIC4, and HHIP in head and neck squamous cell carcinomas.
Paluszczak J; Wiśniewska D; Kostrzewska-Poczekaj M; Kiwerska K; Grénman R; Mielcarek-Kuchta D; Jarmuż-Szymczak M
Clin Oral Investig; 2017 Jun; 21(5):1777-1788. PubMed ID: 27553089
[TBL] [Abstract][Full Text] [Related]
18. Screening key lncRNAs with diagnostic and prognostic value for head and neck squamous cell carcinoma based on machine learning and mRNA-lncRNA co-expression network analysis.
Hu Y; Guo G; Li J; Chen J; Tan P
Cancer Biomark; 2020; 27(2):195-206. PubMed ID: 31815689
[TBL] [Abstract][Full Text] [Related]
19. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
Zhu W; Ye Z; Chen L; Liang H; Cai Q
Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
[TBL] [Abstract][Full Text] [Related]
20. Combined expression and prognostic significance of PPFIA1 and ALG3 in head and neck squamous cell carcinoma.
Zhou H; Cao T; Li WP; Wu G
Mol Biol Rep; 2019 Jun; 46(3):2693-2701. PubMed ID: 30805892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
